LOS GATOS, Calif., Nov. 9, 2023 /PRNewswire/ -- KDx Diagnostics, a pioneering medical device company known for its innovative noninvasive urine test for bladder cancer, the URO17Ò test, is thrilled to ...
A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results